Novartis

NEWS DESK

Department of Health – Abu Dhabi and Novartis Sign Strategic Memorandum of Understanding to Advance Genomics Research and Healthcare Innovation

News Desk 26/06/2026

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate of Abu Dhabi, and Novartis Middle East FZE today signed a Memorandum of Understanding to explore collaboration in genomics research, scientific capacity building, and advanced therapies,

NEWS DESK

NOVARTIS BRINGS ‘TOGETHER WE RIDE’ TO YAS MARINA CIRCUIT IN PARTNERSHIP WITH ABU DHABI PUBLIC HEALTH CENTRE

News Desk 10/06/2026

Yas Marina Circuit successfully hosted a special edition of its flagship TrainYAS community fitness programme, Together We Ride, on 3 June, bringing together more than 1,500 participants for an evening dedicated to movement, wellbeing and community engagement. Presented in partnership with Abu Dhabi Public Health Centre (ADPHC) and brought to you by Novartis, the event

NEWS DESK

Novartis Receives Dual Recognition for Clinical Research Excellence in Saudi Arabia

News Desk 20/02/2026

Novartis commenced 2026 with two significant recognitions in Saudi Arabia, affirming its leadership in clinical research and contributions to the Kingdom’s developing healthcare sector. At the Clinical Trials Transformation Conference: Unraveling the Future in Riyadh, Novartis was awarded First Place in the Clinical Research Contribution Award, presented by King Faisal

NEWS DESK

Understanding lipoprotein(a) and its genetic impact on the heart

PR News Desk 25/09/2025

Novartis today convened leading experts from science, policy, patient advocacy, and clinical care to spotlight elevated lipoprotein(a), or Lp(a) – a little-known but highly prevalent genetic risk factor for cardiovascular disease (CVD) that affect 1 in 5 people worldwide.1 The global educational webinar, titled “Introducing the Little (a) with Big Consequences”, was